DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Ribavirin (Ribavirin) - Life Threatening Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Life Threatening Events (89)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Ribavirin life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 89   Next >>

Possible Ribavirin side effects in 67 year old male

Reported by a pharmacist from United States on 2012-08-24

Patient: 67 year old male

Reactions: Drug Level Below Therapeutic, Anaemia, Deep Vein Thrombosis, Haematoma

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Telaprevir
    Dosage: 750mg, tid, po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-02
    End date: 2012-06-05

Ribavirin
    Dosage: 600 mg, bid, po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-02
    End date: 2012-06-05



Possible Ribavirin side effects in

Reported by a health professional (non-physician/pharmacist) from Belgium on 2012-08-22

Patient:

Reactions: Pulmonary Embolism, Suicide Attempt, Depression, Deep Vein Thrombosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Simvastatin
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-03-11
    End date: 2011-01-07

Simvastatin
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-03-11
    End date: 2011-01-07

Ribavirin
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-03-11
    End date: 2011-01-07

PEG-Intron
    Dosage: 120 micrograms, qw
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-02-11
    End date: 2011-01-06

Placebo
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-03-11
    End date: 2011-01-07

Simvastatin
    Dosage: 800 mg, tid
    Administration route: Oral
    Start date: 2010-03-11
    End date: 2011-01-07

Simvastatin
    Dosage: 800 mg, tid
    Administration route: Oral
    Start date: 2010-03-11
    End date: 2011-01-07

Simvastatin
    Dosage: 800 mg, tid
    Administration route: Oral
    Start date: 2010-03-11
    End date: 2011-01-07

Blinded Boceprevir
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-03-11
    End date: 2011-01-07

Peginterferon Alfa-2B
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-03-11
    End date: 2011-01-07

Simvastatin
    Dosage: 800 mg, tid
    Administration route: Oral
    Start date: 2010-03-11
    End date: 2011-01-07

Rebetol
    Dosage: 600 mg, bid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-02-11
    End date: 2011-01-07

Other drugs received by patient: Norvir; Zolpidem Tatrate; Reyataz; Xanax; Escitalopram Oxalate; Epivir; Imodium; Invirase



Possible Ribavirin side effects in 68 year old female

Reported by a pharmacist from United States on 2012-08-20

Patient: 68 year old female

Reactions: Anaemia, Cough

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Ribavirin



Possible Ribavirin side effects in male

Reported by a physician from United States on 2012-08-17

Patient: male, weighing 65.4 kg (143.8 pounds)

Reactions: Renal Failure

Adverse event resulted in: life threatening event, disablity

Drug(s) suspected as cause:
Incivek
    Indication: Hepatitis C
    Start date: 2012-07-13
    End date: 2012-07-19

Ribavirin
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-07-13
    End date: 2012-07-19

Pegasys
    Indication: Hepatitis C
    Start date: 2012-07-13
    End date: 2012-07-19

Other drugs received by patient: Zantac; Lisinopril; Ramipril



Possible Ribavirin side effects in

Reported by a individual with unspecified qualification from Korea, Republic of on 2012-08-15

Patient:

Reactions: Major Depression

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Boceprevir
    Dosage: 12 df, tid
    Administration route: Oral
    Start date: 2012-05-03
    End date: 2012-05-30

Boceprevir
    Dosage: 12 df, tid
    Administration route: Oral
    Start date: 2012-05-03
    End date: 2012-05-30

Ribavirin
    Dosage: 5 df, bid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-05
    End date: 2012-05-30

Boceprevir
    Dosage: 12 df, tid
    Administration route: Oral
    Start date: 2012-05-03
    End date: 2012-05-30

Boceprevir
    Dosage: 12 df, tid
    Administration route: Oral
    Start date: 2012-05-03
    End date: 2012-05-30

PEG-Intron
    Dosage: 1 df, qw
    Indication: Hepatitis C
    Start date: 2012-04-05
    End date: 2012-05-30

Ribavirin
    Dosage: 5 df, bid
    Administration route: Oral
    Start date: 2012-04-05
    End date: 2012-05-30



Possible Ribavirin side effects in female

Reported by a pharmacist from United States on 2012-08-08

Patient: female, weighing 149.7 kg (329.3 pounds)

Reactions: Myocardial Infarction

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Ribavirin
    Dosage: 600mg bid po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-23
    End date: 2012-07-14

Pegasys
    Dosage: 180mcg weekly sq
    Indication: Hepatitis C
    Start date: 2012-06-23
    End date: 2012-07-14



Possible Ribavirin side effects in male

Reported by a individual with unspecified qualification from United States on 2012-08-08

Patient: male, weighing 148.0 kg (325.6 pounds)

Reactions: Chromatopsia, Loss of Consciousness

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Incivek
    Dosage: 2 tablets 3 times a day 7 to 9 hours apart
    Indication: HIV Infection

Ribavirin
    Dosage: twice a day
    Indication: HIV Infection
    End date: 2012-03-12

Pegasys
    Dosage: 1 a week
    Indication: Hepatitis C
    Start date: 2012-01-12



Possible Ribavirin side effects in

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-08-02

Patient:

Reactions: Confusional State, Anaemia, Ketoacidosis, Ascites, Loss of Consciousness, Haemoglobin Decreased, Multi-Organ Failure, Renal Failure, Platelet Count Decreased, Septic Shock, Blood Glucose Increased

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Ribavirin
    Dosage: 1000 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-07
    End date: 2012-03-13

Victrelis
    Dosage: 800 mg, q8h
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-12-05
    End date: 2012-03-13

Pegasys
    Dosage: 180 ?g, qw
    Indication: Hepatitis C
    Start date: 2011-11-07
    End date: 2012-03-13

Other drugs received by patient: Glyburide; Metformin Hydrochloride; Eprex; Nadolol; Diazepam; Spironolactone; Lasix



Possible Ribavirin side effects in female

Reported by a individual with unspecified qualification from United States on 2012-07-19

Patient: female, weighing 56.7 kg (124.7 pounds)

Reactions: Adverse Event

Adverse event resulted in: life threatening event, disablity

Drug(s) suspected as cause:
Pegasys
    Indication: Hepatitis C
    Start date: 2011-09-03
    End date: 2012-05-13

Pegasys
    Indication: Disease Recurrence
    Start date: 2011-09-03
    End date: 2012-05-13

Incivek
    Dosage: 2 tablets 7-9 hrs apart

Victrelis
    Dosage: 12 a day

Ribavirin
    Dosage: (6) a day



Possible Ribavirin side effects in male

Reported by a pharmacist from United States on 2012-07-17

Patient: male, weighing 116.0 kg (255.2 pounds)

Reactions: Homicidal Ideation, Suicidal Ideation

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Ribavirin
    Dosage: 600mg bid po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-12
    End date: 2012-07-01

Pegasys
    Dosage: 180 mcg weekly sq
    Start date: 2012-01-12
    End date: 2012-07-01

Other drugs received by patient: Aspirin; Temazepam; Percocet; Incivek; Xanax



Possible Ribavirin side effects in male

Reported by a pharmacist from United States on 2012-07-17

Patient: male, weighing 129.3 kg (284.4 pounds)

Reactions: Dehydration, Depression, Treatment Noncompliance, Suicidal Ideation, Influenza Like Illness

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Pegasys
    Dosage: 180 mcg every week sq
    Indication: Hepatitis C
    Start date: 2011-10-03
    End date: 2011-11-28

Ribavirin
    Dosage: 600mg qam + pm every day po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-10-03
    End date: 2011-11-28

Other drugs received by patient: Vitamin B Complex CAP; Methadone Hydrochloride; Metformin Hydrochloride; Prilosec; Prozac; Fish OIL; Multi-Vitamin; Incivek; Lyrica; Lisinopril and Hydrochlorothiazide; Xanax; Vitamin B-12; Vistaril; Glyburide



Possible Ribavirin side effects in 49 year old female

Reported by a physician from United States on 2012-07-03

Patient: 49 year old female

Reactions: Intentional Overdose, Suicide Attempt

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Ribavirin
    Dosage: 600 mg;bid;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Pegasys
    Dosage: 180 mcg;qw;sc
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-09-28
    End date: 2012-02-20

Victrelis
    Dosage: 800 mg;q8h;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Tylenol
    Indication: Product Used FOR Unknown Indication

Other drugs received by patient: Celexa; Remeron



Possible Ribavirin side effects in 37 year old female

Reported by a physician from Brazil on 2012-07-03

Patient: 37 year old female, weighing 66.3 kg (145.9 pounds)

Reactions: Anaemia, Pancytopenia, Fibromyalgia, Apparent Life Threatening Event, Depression, Acute Respiratory Failure, Septic Shock, Influenza

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Ribavirin
    Dosage: 500 mg;q12h;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-16
    End date: 2012-05-27

Victrelis
    Dosage: 800 mcg;q8h;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-13
    End date: 2012-05-27

PEG-Intron
    Dosage: 80 mcg;qw;sc
    Indication: Hepatitis C
    Start date: 2012-03-16
    End date: 2012-05-27

Other drugs received by patient: Clonazepam; Sertraline Hydrochloride



Possible Ribavirin side effects in 60 year old male

Reported by a pharmacist from United States on 2012-06-26

Patient: 60 year old male

Reactions: Angioedema

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Ribavirin
    Dosage: 500 mg;bid;
    Indication: Hepatitis C

Victrelis
    Dosage: 800 mg;q8h; po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-04

Pegasys
    Dosage: 180 mcg;qw;
    Indication: Hepatitis C

Other drugs received by patient: Acetaminophen; Lactulose; Hydrochlorothiazide; Lisinopril



Possible Ribavirin side effects in 53 year old male

Reported by a pharmacist from Canada on 2012-06-26

Patient: 53 year old male, weighing 63.6 kg (139.8 pounds)

Reactions: Speech Disorder, Haemorrhage Intracranial, Gait Disturbance, Hemiplegia

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Pegasys
    Indication: Product Used FOR Unknown Indication

Ribavirin
    Indication: Product Used FOR Unknown Indication



Possible Ribavirin side effects in 39 year old female

Reported by a physician from Spain on 2012-06-25

Patient: 39 year old female

Reactions: Anaemia, Hyponatraemia, Pulmonary Haemorrhage, Renal Failure, NO Therapeutic Response, Oedema, Thrombocytopenia, Asthenia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Ribavirin
    Dosage: 1200 mg;qd; 800 mg;qd;
    Indication: Hepatitis C
    Start date: 2012-03-19
    End date: 2012-04-30

Ribavirin
    Dosage: 1200 mg;qd; 800 mg;qd;
    Indication: Hepatitis C
    Start date: 2012-04-30
    End date: 2012-05-19

Victrelis
    Dosage: 800 mg;q8h;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-04-18
    End date: 2012-05-28

Pegasys
    Dosage: 180 mcg;qw; 135 mcg;qw;
    Indication: Hepatitis C
    Start date: 2012-03-19
    End date: 2012-05-04

Pegasys
    Dosage: 180 mcg;qw; 135 mcg;qw;
    Indication: Hepatitis C
    Start date: 2012-05-04
    End date: 2012-05-18

Other drugs received by patient: Escitalopram; Acetaminophen; Lorazepam; Omeprazole



Possible Ribavirin side effects in female

Reported by a physician from United Kingdom on 2012-06-22

Patient: female

Reactions: Headache, Hypertension

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Blinded NO Treatment Received
    Dosage: double blinded
    Indication: Hepatitis C
    Start date: 2011-10-31

Placebo
    Dosage: double blinded
    Indication: Hepatitis C
    Start date: 2011-10-31

Pegasys
    Dosage: 180 ug, qw
    Indication: Hepatitis C
    Start date: 2011-10-31

Omeprazole
    Administration route: Oral
    Indication: Gastrooesophageal Reflux Disease

Blinded Deb025
    Dosage: double blinded
    Indication: Hepatitis C
    Start date: 2011-10-31

Ribavirin
    Dosage: 600 mg, bid
    Indication: Hepatitis C
    Start date: 2011-10-31

Lansoprazole
    Dosage: 30 mg, qd
    Indication: Gastrooesophageal Reflux Disease
    Start date: 2001-10-20



Possible Ribavirin side effects in 52 year old female

Reported by a individual with unspecified qualification from Poland on 2012-06-19

Patient: 52 year old female

Reactions: Agranulocytosis, Drug Ineffective, Hyperthyroidism

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Ribavirin
    Dosage: dose reduced

Peginterferon Alfa-2B
    Indication: Hepatitis C

Ribavirin
    Indication: Hepatitis C

Methimazole
    Indication: Hyperthyroidism



Possible Ribavirin side effects in 51 year old male

Reported by a physician from Austria on 2012-06-19

Patient: 51 year old male, weighing 90.0 kg (198.0 pounds)

Reactions: Syncope, Brain Abscess, Epilepsy

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 120 mcg;qw;sc
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-09-09

Ribavirin
    Dosage: 1000 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication
    Start date: 2011-09-09

Victrelis
    Dosage: 800 mg;tid;po
    Administration route: Oral
    Indication: Hepatitis C
    End date: 2012-06-15



Possible Ribavirin side effects in female

Reported by a physician from United States on 2012-06-12

Patient: female

Reactions: Overdose, Suicide Attempt

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Victrelis
    Indication: Product Used FOR Unknown Indication

Acetaminophen
    Indication: Product Used FOR Unknown Indication

Ribavirin
    Indication: Product Used FOR Unknown Indication

PEG-Intron
    Indication: Product Used FOR Unknown Indication



Possible Ribavirin side effects in female

Reported by a health professional (non-physician/pharmacist) from Italy on 2012-06-08

Patient: female

Reactions: Thrombocytopenia

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Ribavirin



Possible Ribavirin side effects in female

Reported by a pharmacist from United States on 2012-06-01

Patient: female, weighing 108.9 kg (239.5 pounds)

Reactions: Suicidal Ideation

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Ribavirin
    Dosage: 400mg bid po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-14
    End date: 2012-05-31

PEG-Intron
    Dosage: 150mcg once weekly sq
    Indication: Hepatitis C
    Start date: 2012-03-14
    End date: 2012-05-31



Possible Ribavirin side effects in 51 year old female

Reported by a health professional (non-physician/pharmacist) from United States on 2012-05-30

Patient: 51 year old female

Reactions: Diabetes Mellitus Inadequate Control

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Victrelis
    Dosage: 800 mg;q8h;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-01
    End date: 2012-04-01

Pegasys
    Dosage: 180 mcg;qw;
    Indication: Product Used FOR Unknown Indication

Ribavirin
    Dosage: 600 mg;bid;
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-01-01

Other drugs received by patient: Insulin



Possible Ribavirin side effects in 60 year old male

Reported by a physician from Portugal on 2012-05-29

Patient: 60 year old male

Reactions: Hepatic Neoplasm Malignant

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Peginterferon Alfa-2B
    Dosage: 100 mcg;qw;sc
    Indication: Hepatitis C

Boceprevir (Sch-503034) (800 MG)
    Dosage: 800 mg;q12h;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-10-01
    End date: 2012-04-24

Ribavirin
    Dosage: 1000 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C

Other drugs received by patient: Vitamin B Complex / 00003501 /; Folic Acid



Possible Ribavirin side effects in female

Reported by a physician from United States on 2012-05-14

Patient: female, weighing 78.1 kg (171.8 pounds)

Reactions: Blood Iron Decreased, Vomiting, Skin Exfoliation, Nausea, Anaemia, DRY Skin, Fatigue, Dehydration, Depression, Asthenia, Decreased Appetite, Renal Failure Acute

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Ribavirin
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-08-27
    End date: 2011-11-22

Pegasys
    Indication: Hepatitis C
    Start date: 2011-08-27
    End date: 2011-11-22

Telaprevir
    Dosage: 2 tablets
    Indication: Hepatitis C
    Start date: 2011-08-27
    End date: 2011-11-22

Other drugs received by patient: Metformin HCL



Possible Ribavirin side effects in 59 year old male

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-05-09

Patient: 59 year old male

Reactions: Anaemia, Ketoacidosis, Ascites, Loss of Consciousness, Multi-Organ Failure, Renal Failure, Platelet Count Decreased, Septic Shock, Blood Glucose Increased

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Victrelis
    Dosage: 800 mg;q8h;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-12-05
    End date: 2012-03-13

Pegasys
    Dosage: 180 mcg;qw;sc
    Indication: Hepatitis C
    Start date: 2011-11-07
    End date: 2012-03-13

Ribavirin
    Dosage: 1000 mg;qd;po
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2011-11-07
    End date: 2012-03-13

Other drugs received by patient: Glyburide; Eprex; Nadol; Metformin HCL; Diazepam; Lasix



Possible Ribavirin side effects in 50 year old female

Reported by a physician from United States on 2012-05-08

Patient: 50 year old female

Reactions: Diabetes Mellitus Inadequate Control

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Pegasys
    Indication: Product Used FOR Unknown Indication

Victrelis
    Dosage: 200 mg;qid;po
    Administration route: Oral
    Indication: Hepatitis C

Ribavirin
    Indication: Product Used FOR Unknown Indication



Possible Ribavirin side effects in 79 year old male

Reported by a physician from France on 2012-05-08

Patient: 79 year old male, weighing 60.0 kg (132.0 pounds)

Reactions: Hyperglycaemia, Hypertension, Fall, Cerebral Haemorrhage

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Viraferonpeg
    Dosage: 0.5 mcg/ kg; qw;
    Indication: Hepatitis C
    Start date: 2008-01-16
    End date: 2008-07-26

Ribavirin
    Dosage: 800 mg; qd;
    Indication: Hepatitis C
    Start date: 2008-01-16
    End date: 2008-07-26

Other drugs received by patient: Lantus; Diamicron; Exforge; Metformin HCL; Glucor 50



Possible Ribavirin side effects in 56 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-05-08

Patient: 56 year old male, weighing 49.0 kg (107.8 pounds)

Reactions: Multi-Organ Failure, Rhabdomyolysis, Lactic Acidosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Peginterferon Alfa-2A
    Indication: Hepatitis C
    Start date: 2012-01-24
    End date: 2012-04-10

Janumet
    Administration route: Oral
    Indication: Type 2 Diabetes Mellitus
    End date: 2012-04-10

Telaprevir
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-24
    End date: 2012-04-10

Ribavirin
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-24
    End date: 2012-04-10

Other drugs received by patient: Epoetin Beta



Possible Ribavirin side effects in 60 year old male

Reported by a physician from Portugal on 2012-05-03

Patient: 60 year old male

Reactions: Hepatic Neoplasm Malignant

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Ribavirin
    Dosage: 1000 mg;qd;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Boceprevir (Sch-503034) (800 MG)
    Dosage: 800 mg;q12h;po
    Administration route: Oral
    Indication: Product Used FOR Unknown Indication

Peginterferon Alfa-2B
    Dosage: 100 mcg;qw;sc
    Indication: Product Used FOR Unknown Indication



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014